HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C (Update)

The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (ISDA) released several significant updates to the AASLD-IDSA HCV Guidance. The latest version has been modified to reflect important developments, including the recent approvals of glecaprevir/pibrentasvir and sofosbuvir/velpatasvir/voxilaprevir. Updated recommendations reflecting these approvals are provided throughout the guidance. In addition to updates to all the sections, the following new sections have been added to the Guidance:

View the updated guidance.

About Kim Rodgers

Kim Rodgers serves as a Communications Specialist at NACCHO. Her work includes promoting local health departments' best practices, as well as partner tools and resources, in infectious disease and preparedness through NACCHO's communications channels, storytelling, and outreach to various audiences.

Leave a Reply

Your email address will not be published. Required fields are marked *